Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: 2 - The Untold Story

Here's What to Expect From Thermo Fisher Scientific's Next Earnings Report

Thermo Fisher Scientific is poised to release its second-quarter results later this month, and analysts project a single-digit earnings drop.

Barchart

Is Quest Diagnostics Stock Outperforming the Nasdaq?

While Quest Diagnostics has outshined the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Barchart

How Is Waters Corporation's Stock Performance Compared to Other Healthcare Stocks?

Even though Waters Corporation has outshined the industry peers over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Traders Eye a Breakout in Thermo Fisher Scientific (TMO) Amid Market Undercurrents

While TMO stock has represented one of the biggest market losers, a sentiment reversal could be in the works.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the Nasdaq?

Thermo Fisher Scientific has notably underperformed the Nasdaq Composite over the past year, yet analysts remain bullish about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Thermo Fisher Scientific Stock?

Although Thermo Fisher Scientific has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Newcastle boss Steve Diamond banned after directing obscenity towards match officials

The Newcastle director of rugby was hit with a six-match ban last week

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Steve Diamond’s season-ending ban was for profanity aimed at match officials

Steve Diamond’s season-ending ban came because he hit out at a group of match-day officials before telling the TMO he should retire

The Guardian - UK

Earnings Preview: What to Expect From Thermo Fisher Scientific's Report

Thermo Fisher Scientific will release its first-quarter earnings later this month, and analysts anticipate bottom-line to remain unchanged year over year.

Barchart

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Although Thermo Fisher Scientific has lagged behind the broader S&P 500 index over the past year, analysts remain confident in its long-term growth prospects.

Barchart

What Are Wall Street Analysts’ Target Price for Thermo Fisher Scientific Stock?

Thermo Fisher Scientific has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Mould, money and murder accusations – residents try to oust management on their London housing estate

The organisation managing the Loughborough Estate in Lambeth is beset by complaints of disrepair, damp and vermin – and has made some big claims of its own

The Guardian - UK

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

MarketBeat

Thermo Fisher Scientific's Quarterly Earnings Preview: What You Need to Know

Thermo Fisher Scientific is expected to announce its fourth-quarter results later this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

Barchart

How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks?

While Thermo Fisher Scientific has underperformed the broader medical device industry recently, analysts remain optimistic about the company's future outlook.

Barchart

Thermo Fisher Scientific Stock: Is Wall Street Bullish or Bearish?

Despite Thermo Fisher Scientific’s underperformance relative to the broader market over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Nasdaq Futures Fall on Higher Bond Yields Ahead of Tesla Earnings

December Nasdaq 100 E-Mini futures (NQZ24) are trending down -0.23% this morning as Treasury yields continued to rise on the prospect of less aggressive Federal Reserve interest rate cuts, while investors awaited a slew of corporate earnings reports, with a particular focus on results from “Magnificent Seven” member Tesla.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Stocks to Watch in the Health and Wellness Sector

The health and wellness market is experiencing growth due to the rising prevalence of chronic diseases, increased consumer demand for health products, and substantial sales growth in health insurance and consumer healthcare markets. Therefore, it could be wise to watch top health and wellness stocks: UnitedHealth Group (UNH), Thermo Fisher…

Barchart

Thermo Fisher Scientific's Q3 2024 Earnings: What to Expect

Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts expect a single-digit earnings dip.

StockNews.com

3 Healthcare Stocks for Safe, Steady Growth

The healthcare industry is set for growth due to the growing demand for quality healthcare services and ongoing advancements in medical technology. Hence, investors might consider investing in healthcare stocks, Johnson & Johnson (JNJ), AbbVie (ABBV), and Thermo Fisher Scientific (TMO) for safe and steady growth. Read more….

Barchart

How Is Revvity's Stock Performance Compared to Other Diagnostics & Research Stocks?

Despite Revvity’s underperformance compared to its industry peers over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Quest Diagnostics Stock: Is DGX Outperforming the Healthcare Sector?

Quest Diagnostics has outperformed the broader healthcare sector recently, and analysts are bullish about the stock's future.

The Guardian - UK

The people of Grenfell knew the truth before the fire. It’s we who must learn from them now

The inquiry’s report has increased the anger, not least of a younger generation that wants justice and won’t be silent, says playwright Gillian Slovo

The Guardian - UK

Grenfell: profit was put ahead of people’s lives

Letters: Readers respond to the final Grenfell inquiry report, which paints a disturbing picture of failures in the construction industry and government

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.